Bionano Genomics, Inc. (BNGO) Operating margin 2017–2025
Bionano Genomics, Inc. (BNGO) operating margin by fiscal year — reported operating income divided by reported revenue.
-116.9%FY2025 · since FY2017: -244.3% → -116.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -116.9% | +220.9 pp |
| FY2024 | -337.9% | +258.1 pp |
| FY2023 | -596.0% | -122.3 pp |
| FY2022 | -473.7% | -44.9 pp |
| FY2021 | -428.8% | +24.6 pp |
| FY2020 | -453.4% | -197.9 pp |
| FY2019 | -255.4% | -85.3 pp |
| FY2018 | -170.1% | +74.2 pp |
| FY2017 | -244.3% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More BNGO financial trends
BNGO RevenueBNGO Net incomeBNGO Net marginBNGO Gross profitBNGO Gross marginBNGO Operating incomeBNGO Operating cash flowBNGO Free cash flowBNGO Capital expendituresBNGO Return on equityBNGO Stock buybacksBNGO Dividends paidBNGO Total assetsBNGO Total liabilitiesBNGO Shareholders’ equityBNGO overview →